ReproCELL Incorporated (TYO:4978)
Japan flag Japan · Delayed Price · Currency is JPY
151.00
+6.00 (4.14%)
Apr 25, 2025, 3:30 PM JST

ReproCELL Company Description

ReproCELL Incorporated provides stem cell research and drug discovery services in Japan.

It offers stem cell reagents, including RNA reprogramming, small molecules, growth factors and cytokines, antibodies and staining kits, cell substrates, cryopreservation media, dissociation solution, and transfection reagents; differentiated induced pluripotent stem cell (iPSC) and related reagents, feeder cells, pluripotent stem cells, and synfire induced neurons; 3D cell culture; and labware.

The company also provides research stem cell, genomics, clinical stem cell research, preclinical and drug discovery CRO, precision medicine, human tissue samples, clinical laboratory, diagnostic, and gene editing services.

ReproCELL Incorporated was incorporated in 2003 and is based in Yokohama, Japan.

ReproCELL Incorporated
Country Japan
Founded 2003
Industry Biotechnology
Sector Healthcare
Employees 96
CEO Shuji Yokoyama

Contact Details

Address:
MetLife Shin-Yokohama Building
Yokohama, 222-0033
Japan
Phone 81 45 475 3887
Website reprocell.com

Stock Details

Ticker Symbol 4978
Exchange Tokyo Stock Exchange
Stock Type Common Stock
Fiscal Year April - March
Reporting Currency JPY
ISIN Number JP3974770004
SIC Code 2836

Key Executives

Name Position
Shuji Yokoyama Chief Executive Officer
Daisuke Usui Chief Operating Officer